Primary Site >> Liver Cancer
Gene >> SULF2
| 1. | |||||||||||
| Journal: | Hepatology. 2008 Apr;47(4):1211-22. | ||||||||||
| Title: | Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. | ||||||||||
| Author: | Lai, Jin-Ping|Sandhu, Dalbir S|Yu, Chunrong|Han, Tao|Moser, Catherine D|Jackson, Kenard K|Guerrero, Ruben Bonilla|Aderca, Ileana|Isomoto, Hajime|Garrity-Park, Megan M|Zou, Hongzhi|Shire, Abdirashid M|Nagorney, David M|Sanderson, Schuyler O|Adjei, Alex A|L | ||||||||||
| PMID: | 18318435 | ||||||||||
| 2. | |||||||||||
| Journal: | Future Oncol. 2008 Dec;4(6):803-14. | ||||||||||
| Title: | Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets. | ||||||||||
| Author: | Lai, Jin-Ping|Thompson, James R|Sandhu, Dalbir S|Roberts, Lewis R | ||||||||||
| PMID: | 19086847 | ||||||||||
| 3. | |||||||||||
| Journal: | World J Gastroenterol. 2010 Jul 28;16(28):3521-8. | ||||||||||
| Title: | Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma. | ||||||||||
| Author: | Akutsu, Noriyuki|Yamamoto, Hiroyuki|Sasaki, Shigeru|Taniguchi, Hiroaki|Arimura, Yoshiaki|Imai, Kohzoh|Shinomura, Yasuhisa | ||||||||||
| PMID: | 20653060 | ||||||||||
| 4. | |||||||||||
| Journal: | Hepatology. 2010 Nov;52(5):1680-9. | ||||||||||
| Title: | The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation. | ||||||||||
| Author: | Lai, Jin-Ping|Oseini, Abdul M|Moser, Catherine D|Yu, Chunrong|Elsawa, Sherine F|Hu, Chunling|Nakamura, Ikuo|Han, Tao|Aderca, Ileana|Isomoto, Hajime|Garrity-Park, Megan M|Shire, Abdirashid M|Li, Jia|Sanderson, Schuyler O|Adjei, Alex A|Fernandez-Zapico, Mar | ||||||||||
| PMID: | 20725905 | ||||||||||
| 5. | |||||||||||
| Journal: | Genes Chromosomes Cancer. 2011 Feb;50(2):122-35. | ||||||||||
| Title: | Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival. | ||||||||||
| Author: | Yang, Ju Dong|Sun, Zhifu|Hu, Chunling|Lai, Jinping|Dove, Rebecca|Nakamura, Ikuo|Lee, Ju-Seog|Thorgeirsson, Snorri S|Kang, Koo Jeong|Chu, In-Sun|Roberts, Lewis R | ||||||||||
| PMID: | 21104785 | ||||||||||
| 6. | |||||||||||
| Journal: | J Transl Med. 2011 May 21;9:72. | ||||||||||
| Title: | SULFs in human neoplasia: implication as progression and prognosis factors. | ||||||||||
| Author: | Bret, Caroline|Moreaux, Jerome|Schved, Jean-Francois|Hose, Dirk|Klein, Bernard | ||||||||||
| PMID: | 21599997 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Rep. 2011;1(1):14-19. | ||||||||||
| Title: | The role of glypican-3 in regulating Wnt in hepatocellular carcinomas. | ||||||||||
| Author: | Gao, Wei|Ho, Mitchell | ||||||||||
| PMID: | 22563565 | ||||||||||
| 8. | |||||||||||
| Journal: | Genes Chromosomes Cancer. 2013 Mar;52(3):225-36. | ||||||||||
| Title: | The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling. | ||||||||||
| Author: | Zheng, Xin|Gai, Xiaohong|Han, Shaoshan|Moser, Catherine D|Hu, Chunling|Shire, Abdirashid M|Floyd, Robert A|Roberts, Lewis R | ||||||||||
| PMID: | 23109092 | ||||||||||
| 9. | |||||||||||
| Journal: | BMC Med Genomics. 2014 Mar 11;7:12. | ||||||||||
| Title: | Exploring the molecular causes of hepatitis B virus vaccination response: an approach with epigenomic and transcriptomic data. | ||||||||||
| Author: | Lu, Youtao|Cheng, Yi|Yan, Weili|Nardini, Christine | ||||||||||
| PMID: | 24612962 | ||||||||||
| 10. | |||||||||||
| Journal: | Biol Chem. 2016 Mar;397(3):257-67. | ||||||||||
| Title: | Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma. | ||||||||||
| Author: | Al-Gayyar, Mohammed M H|Abbas, Ahmed|Hamdan, Ahmed M | ||||||||||
| PMID: | 26733159 | ||||||||||
| 11. | |||||||||||
| Journal: | Histochem Cell Biol. 2016 Jul;146(1):85-97. | ||||||||||
| Title: | SULF1/SULF2 reactivation during liver damage and tumour growth. | ||||||||||
| Author: | Graham, Kurtis|Murphy, Joshua I|Dhoot, Gurtej K | ||||||||||
| PMID: | 27013228 | ||||||||||
| 12. | |||||||||||
| Journal: | Cancer Res. 2017 Feb 1;77(3):632-645. | ||||||||||
| Title: | Transcriptional Induction of Periostin by a Sulfatase 2-TGFbeta1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma. | ||||||||||
| Author: | Chen, Gang|Nakamura, Ikuo|Dhanasekaran, Renumathy|Iguchi, Eriko|Tolosa, Ezequiel J|Romecin, Paola A|Vera, Renzo E|Almada, Luciana L|Miamen, Alexander G|Chaiteerakij, Roongruedee|Zhou, Mengtao|Asiedu, Michael K|Moser, Catherine D|Han, Shaoshan|Hu, Chunling | ||||||||||
| PMID: | 27872089 | ||||||||||
| 13. | |||||||||||
| Journal: | Nitric Oxide. 2018 Sep 1;79:68-83. | ||||||||||
| Title: | Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones. | ||||||||||
| Author: | Altinoz, Meric A|Elmaci, Ilhan | ||||||||||
| PMID: | 29030124 | ||||||||||
| 14. | |||||||||||
| Journal: | Oncogene. 2018 Aug;37(32):4443-4454. | ||||||||||
| Title: | Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer. | ||||||||||
| Author: | Yoon, Sarah|Lee, Eun-Ju|Choi, Ji-Hye|Chung, Taek|Kim, Do Young|Im, Jong-Yeop|Bae, Myung-Ho|Kwon, Jung-Hee|Kim, Hyuk-Hoon|Kim, Hyung Chul|Park, Young Nyun|Wang, Hee-Jung|Woo, Hyun Goo | ||||||||||
| PMID: | 29720727 | ||||||||||